Q&A with Oncimmune CEO, Martin Gouldstone

Episode 1824,   Mar 05, 01:09 PM

In this interview, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm offering autoantibody profiling that is used to enable precision medicine within the Biopharma industry.

00:00 What the company does and the current demand picture within the Biopharma sector
09:15 recent contract wins and update on commercialisation strategy